About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Houston | 372 Studies

Clinical Trials HypertensionHouston

Hypertension Clinical Trials in Houston

Find 372 clinical trials for hypertension near Houston, Texas. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 372 trials

CompletedA Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial HypertensionThe main objective of the study is to assess the effect of treprostinil palmitil inhalation powder (TPIP) compared with placebo on pulmonary vascular resistance.NCT05147805·Phoenix, Arizona and 91 others

Hypertension Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedStudy to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular HypertensionThis Phase 1/2a study is intended to assess the safety, tolerability, and effects on intraocular pressure of two dose levels and two dose frequencies of LX7101 when administered…NCT01528111·Morrow, Georgia and 4 others

RecruitingBradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenTA prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm…NCT06059638·Scottsdale, Arizona and 130 others

CompletedAdditivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to TravatanThe purpose of this study is to compare the additive effect on eye pressure of Azopt and Alphagan P to Travatan.NCT00121147·Los Angeles, California and 20 others

CompletedThe Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim WidthThe purpose of this study is to evaluate the use of two instruments to measure changes in two ocular structures: 1) the anterior chamber depth (ACD) - measured using low coherence…NCT03926975·Houston, Texas

CompletedThe Effect of Sorafenib on Portal PressureSorafenib is approved by the US FDA for the treatment of unresectable (can not operate) liver cancer and for renal cell carcinoma.NCT01714609·New Haven, Connecticut and 5 others

CompletedClinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger SyndromeClinical study to assess the efficacy, safety, and tolerability of macitentan in subjects with Eisenmenger Syndrome.NCT01743001·Los Angeles, California and 54 others

CompletedAntibody Secreting Cell and Cyotokine Profiles in Neonates on ECMOInfants are placed on ECMO for correction of reversible respiratory failure.NCT00371241·Houston, Texas

CompletedLong-term Safety and Efficacy of Ralinepag in Pulmonary Arterial HypertensionThis study was an open-label extension study to determine the long-term safety and tolerability of ralinepag in subjects with World Health Organization (WHO) Group 1 pulmonary…NCT02279745·Birmingham, Alabama and 45 others

TerminatedTezosentan in Patients With Pulmonary Arterial HypertensionMulticenter, double-blind, randomized, placebo-controlled, cross-over study to demonstrate that a single infusion of tezosentan has minimal effect on blood pressure in patients…NCT01094067·Houston, Texas and 4 others

CompletedDose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric SubjectsThis was a 4-week, multicenter, double-blind, placebo-controlled, randomized, parallel-group study to determine the antihypertensive dose range, efficacy, safety and tolerability…NCT00255528·Little Rock, Arkansas and 30 others

CompletedTelmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe HypertensionThe primary objective of this trial is to demonstrate that the fixed-dose combination of T80/HCTZ25 is superior as first line therapy in reducing seated trough cuff Systolic Blood…NCT00926289·Athens, Alabama and 105 others

CompletedDiuretics and Volume Overload in Early CKDAlmost 15% of Americans have chronic kidney disease (CKD), with an even higher rate in Veterans due to common risk factors such as high blood pressure and diabetes.NCT05171686·Houston, Texas

CompletedRetrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United StatesThe Opsumit Users registry (OPUS; NCT02126943) was developed to characterize the safety profile of Opsumit and to describe clinical characteristics and outcomes of patients newly…NCT03197688·Phoenix, Arizona and 105 others

CompletedComparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompare the IOP lowering properties of latanoprost, travoprost and bimatoprostNCT00847483·Bellflower, California and 39 others

RecruitingA Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILDThis is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated…NCT07333183·Santa Barbara, California and 12 others

CompletedPulmonary Hypertension, Hypoxia and Sickle Cell DiseaseThe study will look at the risk factors for pulmonary hypertension (high blood pressure in the lungs) in children and adolescents with sickle cell anemia (SCA) and examine the…NCT00495638·Washington D.C., District of Columbia and 6 others

RecruitingExternal Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical TrialThe goal of this phase 1 randomized controlled safety and feasibility clinical trial are to determine the safety of external lumbar drainage (ELD) in select patients with severe…NCT05889650·Gainesville, Florida and 5 others

TerminatedPhase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAHThis is a multi-center, randomized, double-blind, controlled, Phase 2 study to assess the safety, tolerability, and efficacy of pemziviptadil (PB1046) at the optimally titrated…NCT03556020·Mobile, Alabama and 25 others

TerminatedA Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial HypertensionThis is a multi-center, open-label study of sitaxsentan sodium 100 mg taken orally once daily by subjects with PAH until sitaxsentan, in a particular country or region, is…NCT00811018·Birmingham, Alabama and 90 others

PreviousPage 2 of 19Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia